Research reveals that neural crest cells fine-tune key growth signals during early development, ensuring proper formation of ...

In November 2023, the UK became the first country in the world to authorise a Crispr gene-editing therapy.

In Alzheimer’s disease and other dementias, a protein called tau can pile up inside brain cells and form toxic clumps. Those ...

HARRISBURG, PA — Republican leaders in the Pennsylvania House on Tuesday sharply criticized Governor Josh Shapiro’s proposed Fiscal Year 2026–27 budget, warning that the plan expands government too ...

Colossal Biosciences is applying genetics and long-term biostorage to conservation efforts, with research also exploring ...

Delivery of therapeutic genes is essential for gene therapy. Adeno-associated viruses (AAVs) are a prime vector for carrying ...

Nearly 100 biotechs went public amid the industry’s IPO frenzy in 2021, driven by an influx of pandemic-driven investments. But many of those companies have little to show investors.

Researchers at UC San Francisco have identified a hazardous waste collector in the brain that disposes of the toxic clumps of ...

Scientists discovered why some neurons resist tau toxicity, identifying CRL5SOCS4 as a crucial defense and linking ...

GeneDx, a fast-growing biotech doing exome and genomic testing, has seen big returns on Wall Street as appetite for its tests ...

AstraZeneca's $15 billion pledge to its China operations highlights the country's advantages. But other regions are also hoping to host more clinical studies.

Scientists have achieved a genetic feat once thought impossible: removing an entire extra human chromosome using gene-editing ...